Unified Medical Language System® (UMLS®)
2012AB MedDRA Spanish Source Information
Counts
| Attribute Name | Description | Count (MRSAT.RRF) |
|---|---|---|
| SMQ_TERM_ADDVERSION | Standardised MedDRA Query (SMQ) Addition Version. Version of MedDRA in which term was added to the SMQ. | 118064 |
| SMQ_TERM_CAT | Standardised MedDRA Query (SMQ) Term Category. A single alphabetical letter indicating the category of the term for application of the SMQ algorithm. If the SMQ does not use algorithms, then all Term_category values are assigned "A." For a child SMQ, this field is assigned "S." | 118064 |
| SMQ_TERM_LMVERSION | Standardised MedDRA Query (SMQ) Last Modified Version. Version of MedDRA in which term was last modified in the SMQ. | 118064 |
| SMQ_TERM_SCOPE | Standardised MedDRA Query (SMQ) Term Scope. Defines the MedDRA term as a member of the broad scope (1), narrow scope (2) of the SMQ search, or a child SMQ (0) (zero). | 118064 |
| SMQ_TERM_STATUS | Standardised MedDRA Query (SMQ) Term Status. Identifies a term as active ("A") or inactive ("I") within this SMQ. | 118064 |
| SMQ_TERM_WEIGHT | Standardised MedDRA Query (SMQ) Term Weight. Used for some SMQ algorithms; "0" is used as default. | 118064 |
| SMQ_TERM_LEVEL | Standardised MedDRA Query (SMQ) Term Level. The MedDRA hierarchy level of a term (4=PT, 5=LLT) or 0 (zero) for a child SMQ. | 39019 |
| MPS | MedDRA primary SOC (PTs may have multiple treepositions, but each has a primary soc) | 19550 |
| SMQ_ALGO | Standardised MedDRA Query (SMQ) Algorithm. Boolean expression of algorithm for the SMQ. "N" if the SMQ does not utilize an algorithm. | 203 |
| SMQ_LEVEL | Standardised MedDRA Query (SMQ) Level. Value between 1 and 5 identifying the level of the SMQ within the hierarchy of SMQs; 1 is the most general, 5 is the most narrow. | 203 |
| SMQ_STATUS | Standardised MedDRA Query (SMQ) Status. "A" = active; "I" = inactive. | 203 |
| SMQ_SOURCE | Standardised MedDRA Query (SMQ) Source. Source for the development of the SMQ, e.g. medical references. | 163 |
| SOS | Scope Statement | 106 |
| MISO | MedDRA Serial Code International SOC Sort Order Digit (01-26) | 26 |
Notes
- Attributes included every discrete piece of information about a concept, an atom, or a relationship that is not part of the basic Metathesaurus concept structure or distributed in one of the relationship files.
- Attribute Names (ATN) are based on source documentation or NLMs understanding of the source.
- Sample attribute values (ATV) are provided for each ATN in the source.
- Sample data highlight examples of ATNs and Attribute Values (ATV) in MRSAT.RRF.
- See Metathesaurus Documentation for a complete list of attribute names.
- See Section 2.5 of the UMLS Reference Manual for more information on attributes in the UMLS Metathesaurus.
Sample Data
SMQ_TERM_ADDVERSION
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C1869007 | R92324255 | RUI | SMQ_TERM_ADDVERSION | 7.1 | Rabdomilisis/Miopata (SMQ) |
| C0858671 | R92306660 | RUI | SMQ_TERM_ADDVERSION | 7.1 | Insuficiencia renal aguda por urato |
| C1869008 | R92324685 | RUI | SMQ_TERM_ADDVERSION | 8.0 | Insuficiencia renal aguda (SMQ) |
| C0919692 | R92314379 | RUI | SMQ_TERM_ADDVERSION | 10.0 | Edema pulmonar del recin nacido |
| C1869018 | R92325827 | RUI | SMQ_TERM_ADDVERSION | 8.0 | Trastornos congnitos, familiares, neonatales y genticos del hgado (SMQ) |
| C0858790 | R92284485 | RUI | SMQ_TERM_ADDVERSION | 8.1 | Sensacin de ahogo en el pecho |
| C1869027 | R92327999 | RUI | SMQ_TERM_ADDVERSION | 8.1 | Angioedema (SMQ) |
| C0542571 | R92290085 | RUI | SMQ_TERM_ADDVERSION | 8.1 | Edema de cara |
| C1869039 | R92329956 | RUI | SMQ_TERM_ADDVERSION | 10.1 | Depresin y suicidio/autolesin (SMQ) |
| C0424295 | R92293606 | RUI | SMQ_TERM_ADDVERSION | 9.0 | Hiperactivo |
| C0001973 | R92321551 | RUI | SMQ_TERM_ADDVERSION | 9.0 | Abuso del alcohol con comportamiento de bebedor crnico |
| C0017181 | R92282406 | RUI | SMQ_TERM_ADDVERSION | 9.0 | Sangrado gastrointestinal |
| C1869102 | R92331130 | RUI | SMQ_TERM_ADDVERSION | 9.0 | Trminos sobre hemorragia (excl trminos sobre laboratorio) (SMQ) |
| C1869102 | R92331497 | RUI | SMQ_TERM_ADDVERSION | 9.0 | Trminos sobre hemorragia (excl trminos sobre laboratorio) (SMQ) |
| C0854239 | R92316744 | RUI | SMQ_TERM_ADDVERSION | 9.0 | Diverticulitis intestinal hemorrgica |
| C2937358 | R92316840 | RUI | SMQ_TERM_ADDVERSION | 9.0 | Hemorragia intracerebral |
| C0877337 | R92316929 | RUI | SMQ_TERM_ADDVERSION | 9.0 | Hemorragia de la lengua |
| C0156621 | R92320129 | RUI | SMQ_TERM_ADDVERSION | 9.0 | Hemorragia por placenta previa |
| C1869102 | R92332070 | RUI | SMQ_TERM_ADDVERSION | 9.0 | Trminos sobre hemorragia (excl trminos sobre laboratorio) (SMQ) |
SMQ_TERM_CAT
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C0018802 | R92292650 | RUI | SMQ_TERM_CAT | A | Insuficiencia cardiaca, congestiva |
| C1869020 | R92326041 | RUI | SMQ_TERM_CAT | A | Infecciones del hgado (SMQ) |
| C0002878 | R92292287 | RUI | SMQ_TERM_CAT | A | Anemia hemoltica |
| C0235851 | R92280111 | RUI | SMQ_TERM_CAT | B | Empeoramiento de la bilirrubinemia |
| C0026846 | R92299502 | RUI | SMQ_TERM_CAT | A | Atrofia muscular |
| C0038663 | R92309372 | RUI | SMQ_TERM_CAT | A | Intento de suicidio |
| C1869102 | R92330464 | RUI | SMQ_TERM_CAT | A | Trminos sobre hemorragia (excl trminos sobre laboratorio) (SMQ) |
| C1869102 | R92330510 | RUI | SMQ_TERM_CAT | A | Trminos sobre hemorragia (excl trminos sobre laboratorio) (SMQ) |
| C1869102 | R92331132 | RUI | SMQ_TERM_CAT | A | Trminos sobre hemorragia (excl trminos sobre laboratorio) (SMQ) |
| C0236013 | R92293733 | RUI | SMQ_TERM_CAT | A | Estado hiperosmolar |
| C1869043 | R92332686 | RUI | SMQ_TERM_CAT | A | Hiperglucemia/diabetes mellitus recidivante (SMQ) |
| C1869044 | R92333044 | RUI | SMQ_TERM_CAT | A | Enfermedad pulmonar intersticial (SMQ) |
| C1504566 | R92321695 | RUI | SMQ_TERM_CAT | D | Fiebre del algodn |
| C0041956 | R92311960 | RUI | SMQ_TERM_CAT | A | Obstruccin ureteral |
| C1963924 | R92323576 | RUI | SMQ_TERM_CAT | A | Oligoanuria |
| C1869070 | R92338176 | RUI | SMQ_TERM_CAT | A | Demencia (SMQ) |
| C0158945 | R92287026 | RUI | SMQ_TERM_CAT | A | Infeccin congnita por citomegalovirus |
| C1869073 | R92341074 | RUI | SMQ_TERM_CAT | A | Trastornos congnitos, familiares y genticos (SMQ) |
| C0158671 | R92302660 | RUI | SMQ_TERM_CAT | A | Otras anomalas congnitas especificadas de la boca |
SMQ_TERM_LMVERSION
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C1095923 | R92315582 | RUI | SMQ_TERM_LMVERSION | 8.1 | Aplasia febril de la mdula sea |
| C1869027 | R92328067 | RUI | SMQ_TERM_LMVERSION | 8.1 | Angioedema (SMQ) |
| C0235438 | R92307286 | RUI | SMQ_TERM_LMVERSION | 8.1 | Edema sacro |
| C0347950 | R92281315 | RUI | SMQ_TERM_LMVERSION | 8.1 | Ataque asmtico |
| C0853084 | R92292600 | RUI | SMQ_TERM_LMVERSION | 8.1 | HDL elevadas |
| C0235926 | R92292102 | RUI | SMQ_TERM_LMVERSION | 8.1 | Granulocitopenia neonatal |
| C0158219 | R92287745 | RUI | SMQ_TERM_LMVERSION | 8.1 | Dificultad para caminar por afectacin articular de otras localizaciones especificadas |
| C1869037 | R92329726 | RUI | SMQ_TERM_LMVERSION | 8.1 | Neuropata perifrica (SMQ) |
| C1869043 | R92332451 | RUI | SMQ_TERM_LMVERSION | 9.0 | Hiperglucemia/diabetes mellitus recidivante (SMQ) |
| C1869044 | R92332952 | RUI | SMQ_TERM_LMVERSION | 9.0 | Enfermedad pulmonar intersticial (SMQ) |
| C1869050 | R92334927 | RUI | SMQ_TERM_LMVERSION | 9.1 | Sndrome anticolinrgico (SMQ) |
| C0855329 | R92320389 | RUI | SMQ_TERM_LMVERSION | 9.1 | Cambio en el electrocardiograma |
| C1869060 | R92336161 | RUI | SMQ_TERM_LMVERSION | 9.1 | Enfermedades cerebrovasculares isqumicas (SMQ) |
| C0270276 | R92292145 | RUI | SMQ_TERM_LMVERSION | 9.1 | Sndrome gris del recin nacido |
| C0920244 | R92314516 | RUI | SMQ_TERM_LMVERSION | 9.1 | Insuficiencia renal secundaria a rabdomiolisis |
| C0340712 | R92304258 | RUI | SMQ_TERM_LMVERSION | 10.1 | Flebitis y tromboflebitis de las extremidades inferiores, no especificadas |
| C0035229 | R92306929 | RUI | SMQ_TERM_LMVERSION | 10.1 | Fallo respiratorio |
| C1963986 | R92358501 | RUI | SMQ_TERM_LMVERSION | 10.1 | Psicosis y trastornos psicticos (SMQ) |
| C1735892 | R92322859 | RUI | SMQ_TERM_LMVERSION | 10.1 | Romboencefalitis |
SMQ_TERM_SCOPE
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C1869006 | R92324070 | RUI | SMQ_TERM_SCOPE | 2 | Torsade de pointes/prologancin del intervalo QT (SMQ) |
| C1869038 | R92327230 | RUI | SMQ_TERM_SCOPE | 1 | Reaccin anafilctica (SMQ) |
| C1142579 | R92319279 | RUI | SMQ_TERM_SCOPE | 1 | Vmito mucoso |
| C1869027 | R92328230 | RUI | SMQ_TERM_SCOPE | 1 | Angioedema (SMQ) |
| C1869028 | R92328606 | RUI | SMQ_TERM_SCOPE | 1 | Asma/broncoespasmo (SMQ) |
| C1869029 | R92328800 | RUI | SMQ_TERM_SCOPE | 2 | Dislipidemia (SMQ) |
| C1261980 | R92320210 | RUI | SMQ_TERM_SCOPE | 2 | Producto teraputico ineficaz para indicacin no aprobada |
| C0541794 | R92281437 | RUI | SMQ_TERM_SCOPE | 1 | Atrofia de msculo esqueltico |
| C0857160 | R92300644 | RUI | SMQ_TERM_SCOPE | 1 | Entumecimiento de pierna |
| C1869043 | R92332435 | RUI | SMQ_TERM_SCOPE | 1 | Hiperglucemia/diabetes mellitus recidivante (SMQ) |
| C1261997 | R92320227 | RUI | SMQ_TERM_SCOPE | 1 | Tomografa computarizada de arteria coronaria, anormal |
| C1285577 | R92279309 | RUI | SMQ_TERM_SCOPE | 1 | Estado confusional agudo |
| C0740481 | R92293958 | RUI | SMQ_TERM_SCOPE | 1 | Hipotensin asintomtica |
| C1869046 | R92333658 | RUI | SMQ_TERM_SCOPE | 1 | Sndrome neurolptico maligno (SMQ) |
| C1869050 | R92335188 | RUI | SMQ_TERM_SCOPE | 1 | Sndrome anticolinrgico (SMQ) |
| C0857213 | R92286806 | RUI | SMQ_TERM_SCOPE | 1 | Calambre en la parte inferior del abdomen |
| C0151539 | R92306228 | RUI | SMQ_TERM_SCOPE | 1 | Urea aumentada en sangre |
| C1869064 | R92336973 | RUI | SMQ_TERM_SCOPE | 2 | Enfermedades circulatorias o cardiacas asociadas al shock (excl Torsade de pointes) (SMQ) |
| C1869067 | R92337303 | RUI | SMQ_TERM_SCOPE | 1 | Estados de shock txico/sptico (SMQ) |
SMQ_TERM_STATUS
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C1869014 | R92325411 | RUI | SMQ_TERM_STATUS | A | Hepatitis, no infecciosa (SMQ) |
| C1869038 | R92327248 | RUI | SMQ_TERM_STATUS | A | Reaccin anafilctica (SMQ) |
| C0860359 | R92306571 | RUI | SMQ_TERM_STATUS | A | Reintubar |
| C1869029 | R92328729 | RUI | SMQ_TERM_STATUS | A | Dislipidemia (SMQ) |
| C1096516 | R92315864 | RUI | SMQ_TERM_STATUS | A | pH en sangre venosa disminuido |
| C1869102 | R92331611 | RUI | SMQ_TERM_STATUS | A | Trminos sobre hemorragia (excl trminos sobre laboratorio) (SMQ) |
| C0155789 | R92317585 | RUI | SMQ_TERM_STATUS | A | Sangrado de varices de esfago |
| C1504595 | R92321733 | RUI | SMQ_TERM_STATUS | A | Equimosis vulvar |
| C1869043 | R92332606 | RUI | SMQ_TERM_STATUS | A | Hiperglucemia/diabetes mellitus recidivante (SMQ) |
| C0853909 | R92298934 | RUI | SMQ_TERM_STATUS | A | Acidosis metablica exacerbada |
| C0745098 | R92319952 | RUI | SMQ_TERM_STATUS | A | Hiperglucemia inducida por esteroides |
| C0031046 | R92303943 | RUI | SMQ_TERM_STATUS | A | Pericarditis NEOM |
| C1142290 | R92318831 | RUI | SMQ_TERM_STATUS | A | Endocarditis lpica |
| C1869050 | R92334839 | RUI | SMQ_TERM_STATUS | A | Sndrome anticolinrgico (SMQ) |
| C1869050 | R92335012 | RUI | SMQ_TERM_STATUS | A | Sndrome anticolinrgico (SMQ) |
| C1869057 | R92335889 | RUI | SMQ_TERM_STATUS | A | Taquiarritmias ventriculares (SMQ) |
| C0541854 | R92287038 | RUI | SMQ_TERM_STATUS | A | Somnolencia diurna |
| C0011206 | R92287304 | RUI | SMQ_TERM_STATUS | A | Desvaro |
| C0221508 | R92300232 | RUI | SMQ_TERM_STATUS | A | Crisis nerviosa |
SMQ_TERM_WEIGHT
(return to top)| CUI | METAUI | STYPE | ATN | ATV | STR |
|---|---|---|---|---|---|
| C0869270 | R92300484 | RUI | SMQ_TERM_WEIGHT | 0 | Lesiones no alopticas, no clasificadas bajo otro concepto |
| C0159071 | R92300473 | RUI | SMQ_TERM_WEIGHT | 0 | Elevacin no especfica de los niveles de transaminasa o deshidrogenasa del cido lctico (LDH) |
| C0856724 | R92316387 | RUI | SMQ_TERM_WEIGHT | 0 | Bilirrubemia no conjugada |
| C1869025 | R92327544 | RUI | SMQ_TERM_WEIGHT | 0 | Pancreatitis aguda (SMQ) |
| C1704205 | R92310168 | RUI | SMQ_TERM_WEIGHT | 0 | Hinchazn de garganta NEOM |
| C2010560 | R92292983 | RUI | SMQ_TERM_WEIGHT | 0 | Gastritis hemorrgica |
| C0580546 | R92282624 | RUI | SMQ_TERM_WEIGHT | 0 | Glucosa anormal en sangre |
| C0341894 | R92287647 | RUI | SMQ_TERM_WEIGHT | 0 | Diabetes mellitus postparto |
| C1504377 | R92321581 | RUI | SMQ_TERM_WEIGHT | 0 | Sndrome hiperglicmico hiperosmolar no cetsico |
| C0085786 | R92290578 | RUI | SMQ_TERM_WEIGHT | 0 | Alveolitis fibrosante |
| C1698663 | R92322291 | RUI | SMQ_TERM_WEIGHT | 0 | Granulomatosis de Wegener refractaria a tratamiento |
| C1869046 | R92333551 | RUI | SMQ_TERM_WEIGHT | 0 | Sndrome neurolptico maligno (SMQ) |
| C0858754 | R92306106 | RUI | SMQ_TERM_WEIGHT | 0 | Pirexia anormal |
| C0015967 | R92306118 | RUI | SMQ_TERM_WEIGHT | 0 | Pirxico |
| C1869047 | R92334298 | RUI | SMQ_TERM_WEIGHT | 0 | Lupus eritematoso sistmico (SMQ) |
| C1869049 | R92334509 | RUI | SMQ_TERM_WEIGHT | 0 | Infarto de miocardio (SMQ) |
| C1735372 | R92323072 | RUI | SMQ_TERM_WEIGHT | 0 | Taquicardia supraventricular aguda |
| C1869061 | R92336378 | RUI | SMQ_TERM_WEIGHT | 0 | Enfermedades cerebrovasculares hemorrgicas (SMQ) |
| C1869070 | R92337874 | RUI | SMQ_TERM_WEIGHT | 0 | Demencia (SMQ) |
SMQ_TERM_LEVEL
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1737264 | A11343023 | L6191691 | S7105822 | CODE | 10066686 | SMQ_TERM_LEVEL | 5 | Taquicardia ventricular recurrente |
| C1963747 | A13282095 | L6873155 | S8002834 | CODE | 10067389 | SMQ_TERM_LEVEL | 4 | Hepatitis por herpes simplex |
| C0857578 | A11338306 | L4946348 | S5633853 | CODE | 10010935 | SMQ_TERM_LEVEL | 5 | Prueba indirecta de Coombs anormal |
| C1187006 | A11305416 | L4954108 | S5641612 | CODE | 10028126 | SMQ_TERM_LEVEL | 5 | Vescula mucosa NEOM |
| C0263235 | A11308241 | L4925433 | S5612938 | CODE | 10062396 | SMQ_TERM_LEVEL | 5 | Dermatitis exfoliativa generalizada crnica |
| C0264315 | A11295970 | L4927077 | S5614582 | CODE | 10018393 | SMQ_TERM_LEVEL | 5 | Edema gltico |
| C0854390 | A11349703 | L2712682 | S3186739 | CODE | 10040074 | SMQ_TERM_LEVEL | 5 | Septicemia por bacterias anaerobias NEOM |
| C0242966 | A6561241 | L4950725 | S5638230 | CODE | 10053879 | SMQ_TERM_LEVEL | 4 | Sndrome sptico |
| C0920103 | A11307465 | L2701144 | S3175203 | CODE | 10050545 | SMQ_TERM_LEVEL | 5 | Hematotoxicosis |
| C1260899 | A11308293 | L4918716 | S5606221 | CODE | 10062988 | SMQ_TERM_LEVEL | 5 | Anemia de Diamon-Blackfan |
| C0269684 | A11346153 | L4918724 | S5606229 | CODE | 10002303 | SMQ_TERM_LEVEL | 5 | Anemia de la madre, que complica el embarazo, parto o puerperio, sin especif del eda |
| C0023510 | A11312687 | L2697984 | S3172042 | CODE | 10013112 | SMQ_TERM_LEVEL | 5 | Enfermedad de los leucocitos no especificada |
| C0241057 | A11294881 | L2691381 | S3165440 | CODE | 10006792 | SMQ_TERM_LEVEL | 5 | Ardor en la piel |
| C0858549 | A11346222 | L2690327 | S3164386 | CODE | 10003105 | SMQ_TERM_LEVEL | 5 | Alertamiento nocturno |
| C0025193 | A11339813 | L4925340 | S5612845 | CODE | 10027144 | SMQ_TERM_LEVEL | 5 | Depresin melanclica |
| C0860170 | A11330327 | L4932326 | S5619829 | CODE | 10017820 | SMQ_TERM_LEVEL | 5 | Hemorragia de la submucosa gstrica |
| C1399404 | A11304597 | L4952106 | S5639610 | CODE | 10019602 | SMQ_TERM_LEVEL | 5 | Trastorno hemorrgico por anticoagulantes circulantes |
| C0017565 | A11307826 | L4931788 | S5619293 | CODE | 10055796 | SMQ_TERM_LEVEL | 5 | Gingivitis hemorrgica |
| C0151529 | A6479039 | L2358919 | S2794774 | CODE | 10005140 | SMQ_TERM_LEVEL | 4 | Tiempo prolongado de hemorragia |
MPS
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0003504 | A6540554 | L4935498 | S5623003 | SDUI | 10002915 | MPS | 10007541 | Insuficiencia de la vlvula artica |
| C0236792 | A6479540 | L2359196 | S2795051 | SDUI | 10003484 | MPS | 10037175 | Trastorno de Asperger |
| C0855570 | A6469711 | L2353861 | S2789716 | SDUI | 10004498 | MPS | 10022891 | Microglobulina beta 2 normal |
| C0855593 | A6452420 | L2344743 | S2780598 | SDUI | 10004509 | MPS | 10022891 | Beta-N-acetil-D-glucosaminidasa disminuida |
| C0853466 | A6520004 | L4920835 | S5608340 | SDUI | 10004858 | MPS | 10022891 | Biopsia normal de prstata |
| C0853471 | A6452598 | L2344819 | S2780674 | SDUI | 10004863 | MPS | 10022891 | Biopsia anormal de retina |
| C0852793 | A6456227 | L2346684 | S2782539 | SDUI | 10005458 | MPS | 10022891 | Cortisol elevado en sangre |
| C0006060 | A6461892 | L2349691 | S2785546 | SDUI | 10006045 | MPS | 10021881 | Fiebre botonosa |
| C0278485 | A6524985 | L4924362 | S5611869 | SDUI | 10006199 | MPS | 10029104 | Cncer de mama, estadio I |
| C0332686 | A6475298 | L2356946 | S2792801 | SDUI | 10006797 | MPS | 10022117 | Quemaduras de primer grado |
| C0853905 | A6554224 | L4945866 | S5633370 | SDUI | 10007843 | MPS | 10022891 | Proporcin CD4/CD8 disminuida |
| C0007971 | A6475270 | L2356934 | S2792789 | SDUI | 10008417 | MPS | 10017947 | Queilitis |
| C0008627 | A6452368 | L2344715 | S2780570 | SDUI | 10008821 | MPS | 10022891 | Bandeado de cromosomas |
| C0854400 | A6542036 | L4936657 | S5624161 | SDUI | 10009856 | MPS | 10022117 | Lesin por exposicin al fro |
| C0265890 | A6531606 | L4929102 | S5616607 | SDUI | 10010369 | MPS | 10010331 | Estenosis artica congnita |
| C0854546 | A6475678 | L2357171 | S2793026 | SDUI | 10014436 | MPS | 10042613 | Radioterapia cerebral con electrones |
| C0854658 | A6556810 | L4947662 | S5635166 | SDUI | 10014439 | MPS | 10042613 | Radioterapia del odo, nariz o garganta con electrones |
| C0151759 | A6468012 | L2352940 | S2788795 | SDUI | 10018158 | MPS | 10038604 | Leucoplasia genital |
| C0860210 | A10326522 | L4927981 | S5615485 | SDUI | 10018704 | MPS | 10019805 | Enfermedad heptica granulomatosa |
SMQ_ALGO
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1869009 | A12692552 | L6566126 | S7656103 | SDUI | 20000005 | SMQ_ALGO | N | Trastornos hepticos (SMQ) |
| C1869015 | A12694666 | L6566614 | S7653857 | SDUI | 20000011 | SMQ_ALGO | N | Neoplasias hepticas, malignas y no especificadas (SMQ) |
| C1869018 | A12691495 | L6563629 | S7656038 | SDUI | 20000014 | SMQ_ALGO | N | Trastornos congnitos, familiares, neonatales y genticos del hgado (SMQ) |
| C1869023 | A12691497 | L6565283 | S7656098 | SDUI | 20000019 | SMQ_ALGO | N | Trastornos hemolticos (SMQ) |
| C1869027 | A12690435 | L6567839 | S7650389 | SDUI | 20000024 | SMQ_ALGO | N | Angioedema (SMQ) |
| C1869029 | A12694668 | L6564664 | S7651360 | SDUI | 20000026 | SMQ_ALGO | N | Dislipidemia (SMQ) |
| C1869030 | A12691500 | L6563797 | S7650882 | SDUI | 20000027 | SMQ_ALGO | N | Citopenias hematopoyticas (SMQ) |
| C1869036 | A12690436 | L6568587 | S7650219 | SDUI | 20000033 | SMQ_ALGO | N | Acidosis lctica (SMQ) |
| C1869037 | A12692561 | L6568264 | S7653911 | SDUI | 20000034 | SMQ_ALGO | N | Neuropata perifrica (SMQ) |
| C1869039 | A12695717 | L6565478 | S7651241 | SDUI | 20000035 | SMQ_ALGO | N | Depresin y suicidio/autolesin (SMQ) |
| C1869041 | A12691502 | L6563184 | S7652549 | SDUI | 20000038 | SMQ_ALGO | N | Hemorragias (SMQ) |
| C1869102 | A12693635 | L6567761 | S7656353 | SDUI | 20000039 | SMQ_ALGO | N | Trminos sobre hemorragia (excl trminos sobre laboratorio) (SMQ) |
| C1869042 | A12697799 | L6565309 | S7656354 | SDUI | 20000040 | SMQ_ALGO | N | Trminos sobre hemorragia/ laboratorio (SMQ) |
| C1869044 | A12693636 | L6568751 | S7651648 | SDUI | 20000042 | SMQ_ALGO | N | Enfermedad pulmonar intersticial (SMQ) |
| C1869045 | A12696764 | L6563789 | S7650832 | SDUI | 20000043 | SMQ_ALGO | N | Cardiopata isqumica (SMQ) |
| C1869046 | A12693637 | L6566872 | S7655858 | SDUI | 20000044 | SMQ_ALGO | A or (B and C and D) | Sndrome neurolptico maligno (SMQ) |
| C1869047 | A12693638 | L6564952 | S7653429 | SDUI | 20000045 | SMQ_ALGO | A or Sum(Category Term Weight)>6 | Lupus eritematoso sistmico (SMQ) |
| C1869048 | A12690440 | L6569286 | S7656070 | SDUI | 20000046 | SMQ_ALGO | N | Trastornos del gusto y olfato (SMQ) |
| C1869050 | A12692563 | L6565256 | S7655838 | SDUI | 20000048 | SMQ_ALGO | A or (B and C and D) | Sndrome anticolinrgico (SMQ) |
SMQ_LEVEL
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1869008 | A12694665 | L6563248 | S7652963 | SDUI | 20000003 | SMQ_LEVEL | 1 | Insuficiencia renal aguda (SMQ) |
| C1869091 | A12692591 | L6568142 | S7652956 | SDUI | 20000004 | SMQ_LEVEL | 1 | Insuficiencia cardiaca (SMQ) |
| C1869009 | A12692552 | L6566126 | S7656103 | SDUI | 20000005 | SMQ_LEVEL | 1 | Trastornos hepticos (SMQ) |
| C1869022 | A12693629 | L6564462 | S7656106 | SDUI | 20000018 | SMQ_LEVEL | 2 | Trastornos hepticos relacionados con el embarazo (SMQ) |
| C1869024 | A12695715 | L6569223 | S7655489 | SDUI | 20000020 | SMQ_LEVEL | 1 | Reacciones cutneas adversas graves (SMQ) |
| C1869038 | A12690434 | L6563567 | S7655493 | SDUI | 20000021 | SMQ_LEVEL | 1 | Reaccin anafilctica (SMQ) |
| C1869025 | A12691498 | L6565159 | S7655061 | SDUI | 20000022 | SMQ_LEVEL | 1 | Pancreatitis aguda (SMQ) |
| C1869028 | A12693631 | L6568638 | S7650657 | SDUI | 20000025 | SMQ_LEVEL | 1 | Asma/broncoespasmo (SMQ) |
| C1869030 | A12691500 | L6563797 | S7650882 | SDUI | 20000027 | SMQ_LEVEL | 1 | Citopenias hematopoyticas (SMQ) |
| C1869035 | A12692559 | L6565568 | S7651992 | SDUI | 20000032 | SMQ_LEVEL | 1 | Falta de eficacia/efecto (SMQ) |
| C1869036 | A12690436 | L6568587 | S7650219 | SDUI | 20000033 | SMQ_LEVEL | 1 | Acidosis lctica (SMQ) |
| C1869037 | A12692561 | L6568264 | S7653911 | SDUI | 20000034 | SMQ_LEVEL | 1 | Neuropata perifrica (SMQ) |
| C1869040 | A12690438 | L6566869 | S7655821 | SDUI | 20000037 | SMQ_LEVEL | 2 | Suicidio/autolesin (SMQ) |
| C1869041 | A12691502 | L6563184 | S7652549 | SDUI | 20000038 | SMQ_LEVEL | 1 | Hemorragias (SMQ) |
| C1869102 | A12693635 | L6567761 | S7656353 | SDUI | 20000039 | SMQ_LEVEL | 2 | Trminos sobre hemorragia (excl trminos sobre laboratorio) (SMQ) |
| C1869042 | A12697799 | L6565309 | S7656354 | SDUI | 20000040 | SMQ_LEVEL | 2 | Trminos sobre hemorragia/ laboratorio (SMQ) |
| C1869044 | A12693636 | L6568751 | S7651648 | SDUI | 20000042 | SMQ_LEVEL | 1 | Enfermedad pulmonar intersticial (SMQ) |
| C1869046 | A12693637 | L6566872 | S7655858 | SDUI | 20000044 | SMQ_LEVEL | 1 | Sndrome neurolptico maligno (SMQ) |
| C1869047 | A12693638 | L6564952 | S7653429 | SDUI | 20000045 | SMQ_LEVEL | 1 | Lupus eritematoso sistmico (SMQ) |
SMQ_STATUS
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1869006 | A12694664 | L6564433 | S7655912 | SDUI | 20000001 | SMQ_STATUS | A | Torsade de pointes/prologancin del intervalo QT (SMQ) |
| C1869007 | A12695710 | L6567642 | S7655461 | SDUI | 20000002 | SMQ_STATUS | A | Rabdomilisis/Miopata (SMQ) |
| C1869091 | A12692591 | L6568142 | S7652956 | SDUI | 20000004 | SMQ_STATUS | A | Insuficiencia cardiaca (SMQ) |
| C1869009 | A12692552 | L6566126 | S7656103 | SDUI | 20000005 | SMQ_STATUS | A | Trastornos hepticos (SMQ) |
| C1869017 | A12695712 | L6565699 | S7652973 | SDUI | 20000013 | SMQ_STATUS | A | Insuficiencia, fibrosis y cirrosis heptica y otras enferm asociadas con afecciones del hgado (SMQ) |
| C1869023 | A12691497 | L6565283 | S7656098 | SDUI | 20000019 | SMQ_STATUS | A | Trastornos hemolticos (SMQ) |
| C1869025 | A12691498 | L6565159 | S7655061 | SDUI | 20000022 | SMQ_STATUS | A | Pancreatitis aguda (SMQ) |
| C1869028 | A12693631 | L6568638 | S7650657 | SDUI | 20000025 | SMQ_STATUS | A | Asma/broncoespasmo (SMQ) |
| C1869030 | A12691500 | L6563797 | S7650882 | SDUI | 20000027 | SMQ_STATUS | A | Citopenias hematopoyticas (SMQ) |
| C1869035 | A12692559 | L6565568 | S7651992 | SDUI | 20000032 | SMQ_STATUS | A | Falta de eficacia/efecto (SMQ) |
| C1869037 | A12692561 | L6568264 | S7653911 | SDUI | 20000034 | SMQ_STATUS | A | Neuropata perifrica (SMQ) |
| C1869040 | A12690438 | L6566869 | S7655821 | SDUI | 20000037 | SMQ_STATUS | A | Suicidio/autolesin (SMQ) |
| C1869102 | A12693635 | L6567761 | S7656353 | SDUI | 20000039 | SMQ_STATUS | A | Trminos sobre hemorragia (excl trminos sobre laboratorio) (SMQ) |
| C1869042 | A12697799 | L6565309 | S7656354 | SDUI | 20000040 | SMQ_STATUS | A | Trminos sobre hemorragia/ laboratorio (SMQ) |
| C1869044 | A12693636 | L6568751 | S7651648 | SDUI | 20000042 | SMQ_STATUS | A | Enfermedad pulmonar intersticial (SMQ) |
| C1869049 | A12695720 | L6564859 | S7652776 | SDUI | 20000047 | SMQ_STATUS | A | Infarto de miocardio (SMQ) |
| C1869051 | A12692564 | L6567854 | S7650525 | SDUI | 20000049 | SMQ_STATUS | A | Arritmias cardiacas (SMQ) |
| C1869098 | A12693639 | L6569326 | S7656352 | SDUI | 20000050 | SMQ_STATUS | A | Trminos sobre arritmia cardiaca (incl bradiarritmias y taquiarritmias) (SMQ) |
| C1869100 | A12693640 | L6564426 | S7655867 | SDUI | 20000054 | SMQ_STATUS | A | Taquiarritmias (incl taquiarritmias supraventriculares y ventriculares) (SMQ) |
SMQ_SOURCE
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1869008 | A12694665 | L6563248 | S7652963 | SDUI | 20000003 | SMQ_SOURCE | El Manual Merck, Edicin 17 Cecil Textbook of Medicine, Edicin 19 Harrison's Principles of Internal Medicine, Edicin 13 | Insuficiencia renal aguda (SMQ) |
| C1869027 | A12690435 | L6567839 | S7650389 | SDUI | 20000024 | SMQ_SOURCE | 1. Bankowski Z, Bruppacher R, Crusius I et al. Reporting adverse drug reactions, definition of terms and criteria for their use. Consejo para organizaciones internacionales de las ciencias mdicas (CIOMS) 1999 pgs. 12 -13 2. Dorland's Illustrated Medical Dictionary, 28a Edicin, 1994 pg.78 3. Braunwald E, Fauci A and Kasper D. Harrison's Principles of Internal Medicine, 15a Edicin, 2001 pg. 341 y pgs. 1917-1918 4. Beers M and Berkow R. The Merck Manual of diagnosis and therapy, 17a Edicin, fechada 1999 pgs. 1054-56 | Angioedema (SMQ) |
| C1869058 | A12696767 | L6569280 | S7656032 | SDUI | 20000060 | SMQ_SOURCE | The Merck Manual (17a Edicin), 1999 | Trastornos cerebrovasculares (SMQ) |
| C1869063 | A12691505 | L6566845 | S7655666 | SDUI | 20000066 | SMQ_SOURCE | 1. Harrison's Principles of Internal Medicine 16th ed, Mc Graw Hill, 2005, pgs.1581, 1600-1605 2. Dorland's Illustrated Medical Dictionary, 28a Ed, Philadelphia WB Saunders Co. 3. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Ginebra, 1999 4. Harrison's Principles of Internal Medicine 16a Ed, Mc Graw Hill, 2005, pgs.1367-71 | Shock (SMQ) |
| C1869065 | A12693641 | L6563892 | S7651653 | SDUI | 20000068 | SMQ_SOURCE | 1. Harrison's Principles of Internal Medicine 16a Ed, Mc Graw Hill, 2005, pgs. 1581, 1600-1605 2. Dorland's Illustrated Medical Dictionary, 28a Ed, Philadelphia WB Saunders Co. 3. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Ginebra, 1999 4. Harrison's Principles of Internal Medicine 16a Ed, Mc Graw Hill, 2005, pgs.1367-71 | Enfermedades asociadas a Torsade de pointes, shock (SMQ) |
| C1869067 | A12691506 | L6566389 | S7651811 | SDUI | 20000070 | SMQ_SOURCE | 1. Harrison's Principles of Internal Medicine 16a Ed, Mc Graw Hill, 2005, pgs. 1581, 1600-1605 2. Dorland's Illustrated Medical Dictionary, 28a Ed, Philadelphia WB Saunders Co. 3. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Ginebra, 1999 4. Harrison's Principles of Internal Medicine 16a Ed, Mc Graw Hill, 2005, pgs.1367-71 | Estados de shock txico/sptico (SMQ) |
| C1869068 | A12690445 | L6566386 | S7651805 | SDUI | 20000071 | SMQ_SOURCE | 1. Harrison's Principles of Internal Medicine 16a Ed, Mc Graw Hill, 2005, pgs. 1581, 1600-1605 2. Dorland's Illustrated Medical Dictionary, 28a Ed, Philadelphia WB Saunders Co. 3. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Ginebra, 1999 4. Harrison's Principles of Internal Medicine 16a Ed, Mc Graw Hill, 2005, pgs.1367-71 | Estados de shock anafilctico/anafilactoide (SMQ) |
| C1869069 | A12696772 | L6564724 | S7651807 | SDUI | 20000072 | SMQ_SOURCE | 1. Harrison's Principles of Internal Medicine 16a Ed, Mc Graw Hill, 2005, pgs. 1581, 1600-1605 2. Dorland's Illustrated Medical Dictionary, 28a Ed, Philadelphia WB Saunders Co. 3. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Ginebra, 1999 4. Harrison's Principles of Internal Medicine 16a Ed, Mc Graw Hill, 2005, pgs.1367-71 | Estados de shock hipoglucmico y neurognico (SMQ) |
| C1869075 | A12696773 | L6563825 | S7651093 | SDUI | 20000079 | SMQ_SOURCE | 1. Harrison's en lnea, www.accessmedicine.com Chapter 348, accedido el 29 de mayo de 2005. 2. Bankowski Z, Bruppacher R, Crusius I et al. Reporting adverse drug reactions, definition of terms and criteria for their use. Council for International Organizations of Medical Sciences (CIOMS), 1999. Pgs. 24-25. 3. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:489-501, 1981. | Convulsiones (SMQ) |
| C1869087 | A12694679 | L6566161 | S7656351 | SDUI | 20000091 | SMQ_SOURCE | 1.DeVita VT, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. 7a Edicin, 2005. 2.Peckham, M; Pinedo, H,.Veronesi, U. Oxford Textbook of Oncology. 1995 3.European Group on Tumour Markers (EGTM). http://egtm.web.med.uni-muenchen.de | Tumores malignos o no especificados (SMQ) |
| C1869090 | A12697806 | L6566568 | S7653483 | SDUI | 20000094 | SMQ_SOURCE | 1.DeVita VT, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. 7a Edicin, 2005. 2.Peckham, M; Pinedo, H,.Veronesi, U. Oxford Textbook of Oncology. 1995 3.European Group on Tumour Markers (EGTM). http://egtm.web.med.uni-muenchen.de | Marcadores tumorales (SMQ) |
| C1963980 | A13283969 | L6873669 | S8002900 | SDUI | 20000111 | SMQ_SOURCE | Reporting Adverse Drug Reactions - Definitions of terms and criteria for their use. Council for International Organizations of Medical Sciences (CIOMS); 1999. Dorland's Illustrated Medical Dictionary - Saunders 2003, 30a Ed | Infecciones orofarngeas (SMQ) |
| C1963982 | A13283687 | L6873471 | S8003283 | SDUI | 20000113 | SMQ_SOURCE | Reporting Adverse Drug Reactions - Definitions of terms and criteria for their use. Council for International Organizations of Medical Sciences (CIOMS); 1999. Dorland's Illustrated Medical Dictionary - Saunders 2003, 30a Ed | Trastornos gingivales (SMQ) |
| C1963985 | A13282836 | L6873748 | S8002477 | SDUI | 20000116 | SMQ_SOURCE | The Merck Manual accedido en lnea, 12 Enero 2006: http://www.merck.com/mmpe/sec06/ch065/ch065c.html?qt=acute%20respiratory&alt=sh . Harrison's Principles of Internal Medicine, accedido en lnea, 12 Enero 2006. | Depresin respiratoria aguda central (SMQ) |
| C1963986 | A13283397 | L6873831 | S8003120 | SDUI | 20000117 | SMQ_SOURCE | Dorland's Illustrated Medical Dictionary, 29a Ed, WB Saunders 2004. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4a Ed. Washington, DC, 1994. | Psicosis y trastornos psicticos (SMQ) |
| C1963999 | A13283689 | L6873794 | S8002853 | SDUI | 20000130 | SMQ_SOURCE | Simonneau G, Galie N, Rubin L et al. Clinical classification of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:S5-12. ESC Guidelines on diagnosis and treatment of pulmonary arterial hypertension. European Heart Journal (2004) 25, 2243-2278. Barst RJ, McGoon M, Torbicki A et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:40S- 47S. McGoon M, Gutterman D, Steen V et al.Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2004, 126:14S-34S. Rubin LJ. Executive summary: Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126;4S-6S. | Hipertensin pulmonar (SMQ) |
| C1964001 | A13283401 | L6873754 | S8002540 | SDUI | 20000132 | SMQ_SOURCE | 1) Andreoli T, Behrman R, Bhattacharya B et al. Dorland's Illustrated Medical Dictionary, 30a Ed, 2003. Saunders, Philadelphia. 2) Beehrs M and Berkow R. The Merck Manual of Diagnosis and Therapy. 17a Ed; 1999: 1431-42. 3) Kasper D, Braunwald E, Fauci A, et al. Harrison's Principles of Internal Medicine. 16a Ed, 2005, pgs. 2480-83. | Encefalitis no infecciosa (SMQ) |
| C2242745 | A14227732 | L7592287 | S8790083 | SDUI | 20000145 | SMQ_SOURCE | Schroth, BE. Evaluation and management of peripheral edema. J Amer Acad Phys Assist , http://jaapa.com/issues/j20051101/articles/edema1105.htm. Harrison's Internal Medicine. Dorland's Medical Dictionary. Stedman's Medical Dictionary 27a Ed., 2000 | Edema hemodinmico, derrames y sobrecarga de lquido (SMQ) |
| C1869007 | A12695710 | L6567642 | S7655461 | SDUI | 20000002 | SMQ_SOURCE | Basic requirements for the use of terms for reporting adverse drug reactions (IV). Pharmacoepidemiology and Drug Safety 1993; 2:149-153. Myopathy. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pg. 16-17. Poels PJE and Gabrels FJM. Rhabdomyolysis: a review f the literature. Clin Neurol Neurosurg 1993; 95:175-192. Omar MA, Wilson JP, and Cox, TS. Rhabdomyolysis and HMG-CoA reductase inhibitors. Annals Pharmacother 2001; 35:1096-1107. Prendergast BD and George CF. Drug-induced rhabdomyolysis - mechanisms and management. Postgrad Med J 1993; 69:333-336. | Rabdomilisis/Miopata (SMQ) |
SOS
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C1869006 | A12694664 | L6564433 | S7655912 | SDUI | 20000001 | SOS | 1. Incluye trminos relativos a muerte sbita y muerte de origen cardiaco por estar estos frecuentemente asociados al Torsade de Pointes. | Torsade de pointes/prologancin del intervalo QT (SMQ) |
| C1869007 | A12695710 | L6567642 | S7655461 | SDUI | 20000002 | SOS | 1. Se han incluido trminos relativos a los conceptos de dao renal crnico e isuficiencia renal por su asociacin frecuente a la rabdomiolisis | Rabdomilisis/Miopata (SMQ) |
| C1869038 | A12690434 | L6563567 | S7655493 | SDUI | 20000021 | SOS | Se utiliza el siguiente algoritmo: todos los trminos de bsqueda especfica as como: si est presente un trmino de la categora B y un trmino de la categora C, o un trmino de (la categora B o categora C) adems de un trmino de la categora D. | Reaccin anafilctica (SMQ) |
| C1869025 | A12691498 | L6565159 | S7655061 | SDUI | 20000022 | SOS | Para aplicar el algoritmo: una notificacin es considerada un caso importante para mayor evaluacin si: 1) incluye un trmino de la Categora A (trminos especficos) O 2) incluye por lo menos un trmino de la Categora B (la lista de los valores analticos) y por lo menos un trmino de la Categora C (la lista de los signos y sntomas) | Pancreatitis aguda (SMQ) |
| C1869026 | A12691499 | L6568591 | S7650261 | SDUI | 20000023 | SOS | Si es posible deben notificarse hemogramas completos y recuentos repetidos de leucocitos, indicados como seguimiento y codificados. Con respecto a consultas en la base de datos con trminos de bsqueda general, los datos codificados adicionalmente para valores hematolgicos ayudan a encontrar ms fcilmente los casos pertinentes. En caso de que los valores analticos no estn codificados en una base de datos, es necesario entonces examinar individualmente para decidir su relevancia en el contexto de agranulocitosis. | Agranulocitosis (SMQ) |
| C1869035 | A12692559 | L6565568 | S7651992 | SDUI | 20000032 | SOS | Actualmente, esta SMQ es ms apropiada para frmacos; componentes/derivados de la sangre; y productos para terapia celular, tisular y gnica. Es menos apropiada para vacunas (los productos) que parece estar mejor adecuada para las bsquedas especializadas descritas en este documento. Esta SMQ no es apropiada para dispositivos. El usuario puede modificar esta SMQ para tipos y clases de productos especficos. Remtase a la Gua introductoria para las SMQ para hallar los detalles. | Falta de eficacia/efecto (SMQ) |
| C1869036 | A12690436 | L6568587 | S7650219 | SDUI | 20000033 | SOS | Pruebas hechas en dos bases de datos de especialidades farmacuticas confirmaron que la inclusin del trmino es adecuada; en la base de datos de especialidades farmacuticas, el trmino "acidosis" identificaba casos, pero este puede ser un fenmeno de las caractersticas de la base de datos (codificacin literal de terminologa antigua u otras convenciones para codificacin). | Acidosis lctica (SMQ) |
| C1869091 | A12692591 | L6568142 | S7652956 | SDUI | 20000004 | SOS | El Grupo de trabajo del CIOMS deliber exhaustivamente si poda aplicarse un algoritmo a esta SMQ basndose en la definicin provista de insuficiencia cardiaca. Sin embargo, el Grupo de trabajo del CIOMS no ha probado dicho algoritmo; por lo tanto, el Grupo de trabajo solicita a los usuarios comentar sobre la relevancia prctica de un planteamiento algortmico. Un algoritmo as podra incluir trminos generales como los siguientes: un trmino edema, un trmino disnea adems de un sntoma/signo clnico o uno sobre exploraciones complementarias formando 3 trminos en total | Insuficiencia cardiaca (SMQ) |
| C1869039 | A12695717 | L6565478 | S7651241 | SDUI | 20000035 | SOS | En la bsqueda de Depresin y la bsqueda de Suicidio/autolesin estn incluidos los trminos PT Sobredosis intencional y PT Intoxicacin intencional porque sus trminos LLT son indicativos de suicidio o autolesin. Sin embargo, la inclusin de estos trminos PT (particularmente el PT Sobredosis intencional) aumento sustancialmente la cantidad de casos identificados tanto por las bsquedas de depresin como de suicidio/autolesin en la prueba de Fase I. La prctica de la empresa que haca las pruebas era codificar cualquier caso en el que se prescriba al paciente una dosis que exceda la dosis diaria mxima en la etiqueta como una sobredosis intencional, sin tener en cuenta de si se notificaba una sobredosis o no. Por lo tanto, muchos de estos casos no incluyen verdaderas "sobredosis". En las bases de datos donde sta es una prctica comn, no sera irrazonable realizar una bsqueda inicial excluyendo estos dos trminos PT. En las bases de datos donde sta no es una prctica comn, estos dos trminos PT deben incluirse regularmente en ambas bsquedas. | Depresin y suicidio/autolesin (SMQ) |
| C1869041 | A12691502 | L6563184 | S7652549 | SDUI | 20000038 | SOS | El PT Sangre en orina est incluido aunque pudiera interpretarse slo como una prueba analtica sin indicar explcitamente la presencia de sangre en la orina. Sin embargo, este trmino suele usarse para describir el hallazgo de sangre en la orina. Nota: Los codificadores debieron haber elegido el PT Presencia de hematuria si su propsito era codificar la presencia de sangre en la orina (macroscpicamente incluso sin una prueba). | Hemorragias (SMQ) |
| C1869043 | A12694670 | L6564843 | S7652686 | SDUI | 20000041 | SOS | En la prueba en Fase I (base de datos de la empresa), algunos trminos PT de bsqueda general (Colesterol elevado en sangre, Triglicridos elevados en sangre, Peso disminuido y Peso aumentado) recuperaron bastantes "ecos", pero esto puede depender de los frmacos elegidos para la prueba. El Grupo de trabajo del CIOMS ha concluido que estos trminos PT necesitan incluirse en consideracin a la integridad, y si la bsqueda especfica identifica una cantidad suficiente de casos para evaluacin, entonces podra no ser necesario seguir evaluando los casos que notifican slo estos trminos PT. Sin embargo, si la bsqueda especfica recupera una cantidad insuficiente de casos para evaluacin, entonces los casos que notifican estos trminos PT deben evaluarse para determinar si el paciente en esos casos parece estar en alto riesgo de desarrollar posteriormente diabetes mellitus o hiperglucemia. Pruebas efectuadas en la base de datos del registro sanitario recuperaron igualmente "ecos" para el trmino PT Peso aumentado; sin embargo, el Grupo de trabajo del equipo de desarrollo del CIOMS acept que este trmino es pertinente para el mbito de la SMQ y debe mantenerse en la bsqueda por ahora. Se solicita a los usuarios de MedDRA concentrarse especficamente en este trmino durante la prueba en Fase II y enviar sus observaciones sobre la utilidad global de esta SMQ | Hiperglucemia/diabetes mellitus recidivante (SMQ) |
| C1869045 | A12696764 | L6563789 | S7650832 | SDUI | 20000043 | SOS | Basndose en pruebas de empresas y del registro sanitario, la SMQ Cardiopata isqumica pudo recuperar casos pertinentes La versin original de las bsquedas generales incluy los trminos PT Aspartato aminotransferasa anormal y PT Aspartato aminotransferasa elevada o Se suprimieron estos trminos segn los resultados de la prueba (recuperaron una gran cantidad de casos irrelevantes) o Si se examina datos antiguos (p.ej. anteriores al ao 2000), podra considerarse la inclusin de estos trminos en la consulta Consta de la SMQ Cardiopata isqumica de bsqueda principal y una sola SMQ Infarto de miocardio de subbsqueda, cada una con bsquedas especficas y generales (NOTA: Todos los trminos en la SMQ Infarto de miocardio tambin estn en la SMQ ms amplia Cardiopata isqumica). | Cardiopata isqumica (SMQ) |
| C1869047 | A12693638 | L6564952 | S7653429 | SDUI | 20000045 | SOS | Use del algoritmo de "valores" en esta SMQ: 1. Los trminos PT mencionados en el caso notificado estn agrupados segn las categoras predeterminadas. La presencia de mltiples trminos PT dentro de una categora se cuenta slo una vez 2. La categora a la que se atribuye el trmino es entonces multiplicada por su "valor" predeterminado empricamente (p.ej. 3 para las categoras Trastorno hematolgico, Serositis y Trastorno inmunolgico) y sumado para todas las categoras 3. Si esta suma es mayor que 6, se propone que el caso notificado se cuente como una notificacin de sospecha de LES. Por ejemplo, un caso notificado que contiene trminos PT en las categoras de Trastorno hematolgico (3), Trastorno inmunolgico (3) y Trastorno renal (1) se clasificar como un caso notificado de LES de bsqueda general (3 + 3 + 1 = 7) | Lupus eritematoso sistmico (SMQ) |
| C1869048 | A12690440 | L6569286 | S7656070 | SDUI | 20000046 | SOS | En la prueba en Fase I, los casos en la base de datos de una empresa que describen sabor y olor desagradable de la sustancia mdica tambin se codificaron usando los mismos trminos (p.ej. Disgeusia).La evaluacin mdica es necesaria para distinguir entre las notificaciones del trastorno mdico y las propiedades fsicas del compuesto farmacolgico | Trastornos del gusto y olfato (SMQ) |
| C1869050 | A12692563 | L6565256 | S7655838 | SDUI | 20000048 | SOS | 'Categora A (especfico): Los casos codificados con el PT Sndrome anticolinrgico Categoras B, C y D (general): Categora B (trminos PT relacionados con el sistema nervioso) Categora C (trminos PT relacionados con trastornos psiquitricos Categora D (otros trminos PT pertinentes relacionados con el sndrome anticolinrgico) Los casos a seleccionarse para mayor evaluacin incluiran cualquier caso que notifique el trmino PT incluido en la Categora A o cualquier caso que notifique una combinacin de por lo menos un PT de cada uno de los tres grupos de trminos PT incluidos en las Categoras B, C y D. Nota: Para identificar estos casos, entonces debe tomarse un planteamiento no algortmico para la bsqueda general; sin embargo, este planteamiento puede identificar una gran cantidad de casos irrelevantes. | Sndrome anticolinrgico (SMQ) |
| C1869051 | A12692564 | L6567854 | S7650525 | SDUI | 20000049 | SOS | Para la prueba en Fase II, se pide a los usuarios probar la SMQ Arritmias cardiacas y sus subordinadas excepto la SMQ subordinada Torsade de pointes/prolongacin del intervalo QT, que ya se divulg anteriormente para la prueba en Fase II y que se encuentra actualmente en produccin. | Arritmias cardiacas (SMQ) |
| C1869062 | A12692567 | L6567215 | S7652011 | SDUI | 20000065 | SOS | La bsqueda especfica pudo recuperar la mayora de los casos pertinentes. Al agregar el PT Dolor abdominal a la bsqueda general se recuperaron muchos casos adicionales que no se hubieran obtenido mediante la bsqueda especfica. Por ello, en esta consulta estn incluidos los trminos PT Dolor abdominal y PT Dolor en la zona inferior del abdomen. | Fibrosis retroperitoneal (SMQ) |
| C1869076 | A12697802 | L6562973 | S7650897 | SDUI | 20000080 | SOS | Los trminos Diarrea y Diarrea hemorrgica deben incluirse en la bsqueda especfica si el compuesto es un antibitico; deben permanecer en la bsqueda general si el compuesto no es un antibitico. El PT Infeccin por clostridium incluye los LLT para descripciones "clostridium" no especficas, as como para especies distintas al C. difficile; los casos identificados mediante el PT Infeccin por clostridium deben examinarse cuidadosamente para decidir la relevancia. | Colitis pseudomembranosa (SMQ) |
| C1869077 | A12690446 | L6563717 | S7650229 | SDUI | 20000081 | SOS | Para obtener todos los trminos pertinentes de embolia y trombosis, puede ser necesario combinar las subordinadas de esta SMQ. Deben tenerse en cuenta tambin las SMQ Accidentes cerebrovasculares, SMQ Vasculitis y SMQ Tromboflebitis. | Acontecimientos emblicos y trombticos (SMQ) |
MISO
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0851353 | A6563679 | L4952482 | S5639987 | SDUI | 10005329 | MISO | 03 | Trastornos de la sangre y del sistema linftico |
| C0018799 | A6480007 | L2359545 | S2795400 | SDUI | 10007541 | MISO | 11 | Trastornos cardiacos |
| C0851352 | A6563622 | L4952428 | S5639933 | SDUI | 10010331 | MISO | 21 | Trastornos congnitos, familiares y genticos |
| C0851354 | A6563776 | L4952577 | S5640082 | SDUI | 10013993 | MISO | 10 | Trastornos del odo y del laberinto |
| C0014130 | A6480264 | L2359799 | S2795654 | SDUI | 10014698 | MISO | 05 | Trastornos endocrinos |
| C0015397 | A6480375 | L2359913 | S2795768 | SDUI | 10015919 | MISO | 09 | Trastornos oculares |
| C0017178 | A6480290 | L2359825 | S2795680 | SDUI | 10017947 | MISO | 14 | Trastornos gastrointestinales |
| C0851362 | A6563827 | L4952627 | S5640132 | SDUI | 10018065 | MISO | 22 | Trastornos generales y alteraciones en el lugar de administracin |
| C0267792 | A6480308 | L2359843 | S2795698 | SDUI | 10019805 | MISO | 15 | Trastornos hepatobiliares |
| C0021053 | A6563786 | L4952587 | S5640092 | SDUI | 10021428 | MISO | 04 | Trastornos del sistema inmunolgico |
| C0009450 | A6466256 | L2351908 | S2787763 | SDUI | 10021881 | MISO | 01 | Infecciones e infestaciones |
| C0947733 | A6541731 | L4936423 | S5623928 | SDUI | 10022117 | MISO | 24 | Lesiones traumticas, intoxicaciones y complicaciones de procedimientos teraputicos |
| C1261322 | A6461292 | L2349383 | S2785238 | SDUI | 10022891 | MISO | 23 | Exploraciones complementarias |
| C0851358 | A6563755 | L4952556 | S5640061 | SDUI | 10027433 | MISO | 06 | Trastornos del metabolismo y de la nutricin |
| C0263660 | A6563890 | L4952688 | S5640193 | SDUI | 10028395 | MISO | 17 | Trastornos musculoesquelticos y del tejido conjuntivo |
| C0027651 | A6547896 | L4940980 | S5628485 | SDUI | 10029104 | MISO | 02 | Neoplasias benignas, malignas y no especificadas (incl quistes y plipos) |
| C0027765 | A6480232 | L2359768 | S2795623 | SDUI | 10029205 | MISO | 08 | Trastornos del sistema nervioso |
| C0851363 | A6458846 | L2348028 | S2783883 | SDUI | 10036585 | MISO | 19 | Embarazo, puerperio y enfermedades perinatales |
| C0004936 | A6563938 | L4952732 | S5640241 | SDUI | 10037175 | MISO | 07 | Trastornos psiquitricos |
